Assembly and interrogation of Alzheimer's disease genetic networks reveal novel regulators of progression

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Aubry, Soline ^a   Shin, William ^b   Crary, John F ^a   Lefort, Roger ^a   Qureshi, Yasir H ^a   Lefebvre, Celine ^b,c   Califano, Andrea ^b   Shelanski, Michael L ^a  

^a Department of Medicine   (United States)

^b Department of Systems Biology Columbia University ^*  (United States)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; PROTEIN ZMYM3; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; NERVE PROTEIN;

ACETYLATION; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC ALGORITHM; GENETIC IDENTIFICATION; HIPPOCAMPUS; HUMAN; HUMAN CELL; MALE; NONHUMAN; PHYLOGENETIC TREE; RAT; REVERSE ENGINEERING; SYSTEMS BIOLOGY; TRANSCRIPTION REGULATION; VALIDATION STUDY; VISUAL CORTEX; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; ANIMALS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; NERVE TISSUE PROTEINS; RATS;

EID: 84924975742     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120352     Document Type: Article

References (64)

1. WHO (2011) Global Health and Aging. World Health Organization.
2. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487-498. PMID: 1673054
3. Thinakaran G, Koo EH (2008) Amyloid precursor protein trafficking, processing, and function. J Biol Chem 283: 29615-29619. doi: 10.1074/jbc.R800019200 PMID: 18650430
4. Wilson CA, Doms RW, Lee VM (1999) Intracellular APP processing and A beta production in Alzheimer disease. J Neuropathol Exp Neurol 58: 787-794. PMID: 10446803
5. Lefort R, Pozueta J, Shelanski M (2012) Cross-linking of cell surface amyloid precursor protein leads to increased beta-amyloid peptide production in hippocampal neurons: implications for Alzheimer's disease. J Neurosci 32: 10674-10685. doi: 10.1523/JNEUROSCI.6473-11.2012 PMID: 22855816
6. Moolman DL, Vitolo OV, Vonsattel JP, Shelanski ML (2004) Dendrite and dendritic spine alterations in Alzheimer models. J Neurocytol 33: 377-387. PMID: 15475691
7. Pozueta J, Lefort R, Shelanski ML (2012) Synaptic changes in Alzheimer's disease and its models. Neuroscience.
8. Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response?Nat Med 12: 1005-1015. PMID: 16960575
9. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, et al. (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and upregulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70: 462-473. PMID: 12391607
10. Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, et al. (2008) Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci U S A 105: 4441-4446. doi: 10.1073/pnas.0709259105 PMID: 18332434
11. Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R (2001) A gene expression profile of Alzheimer's disease. DNA Cell Biol 20: 683-695. PMID: 11788046
12. Noorbakhsh F, Overall CM, Power C (2009) Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology. Trends Neurosci 32: 88-100. doi: 10.1016/j.tins.2008.10.003 PMID: 19135729
13. Califano A, Butte AJ, Friend S, Ideker T, Schadt E (2012) Leveraging models of cell regulation and GWAS data in integrative network-based association studies. Nat Genet 44: 841-847. doi: 10.1038/ng.2355 PMID: 22836096
14. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, et al. (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463: 318-325. doi: 10.1038/nature08712 PMID: 20032975
15. Della Gatta G, Palomero T, Perez-Garcia A, Ambesi-Impiombato A, Bansal M, et al. (2012) Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL. Nat Med 18: 436-440. doi: 10.1038/nm.2610 PMID: 22366949
16. Lefebvre C, Rajbhandari P, Alvarez MJ, Bandaru P, Lim WK, et al. (2010) A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol Syst Biol 6: 377. doi: 10.1038/msb.2010.31 PMID: 20531406
17. Piovan E, Yu J, Tosello V, Herranz D, Ambesi-Impiombato A, et al. (2013) Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia. Cancer Cell 24: 766-776. doi: 10.1016/j.ccr.2013.10.022 PMID: 24291004
18. Miller JA, Oldham MC, Geschwind DH (2008) A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. J Neurosci 28: 1410-1420. doi: 10.1523/JNEUROSCI.4098-07.2008 PMID: 18256261
19. Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, et al. (2013) Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153: 707-720. doi: 10.1016/j.cell.2013.03.030 PMID: 23622250
20. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, et al. (2008) Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol Genomics 33: 240-256. doi: 10.1152/physiolgenomics.00242.2007 PMID: 18270320
21. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, et al. (2010) Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology. Neurobiol Aging 31: 549-566. doi: 10.1016/j.neurobiolaging.2008.05.013 PMID: 18572275
22. Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, et al. (2005) Reverse engineering of regulatory networks in human B cells. Nat Genet 37: 382-390. PMID: 15778709
23. van der Maaten L, Hinton G (2008) Visualizing data using t-SNE. Journal of Machine Learning Research 9: 2579-2605.
24. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550. PMID: 16199517
25. Ball MJ (1977) Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study. Acta Neuropathol 37: 111-118. PMID: 848276
26. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225: 1168-1170. PMID: 6474172
27. Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA (2011) A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci 12: 585-601. doi: 10.1038/nrn3085 PMID: 21897434
28. He Y, Casaccia-Bonnefil P (2008) The Yin and Yang of YY1 in the nervous system. J Neurochem 106: 1493-1502. doi: 10.1111/j.1471-4159.2008.05486.x PMID: 18485096
29. Krippner-Heidenreich A, Walsemann G, Beyrouthy MJ, Speckgens S, Kraft R, et al. (2005) Caspase-dependent regulation and subcellular redistribution of the transcriptional modulator YY1 during apoptosis. Mol Cell Biol 25: 3704-3714. PMID: 15831475
30. Pompl PN, Yemul S, Xiang Z, Ho L, Haroutunian V, et al. (2003) Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease. Arch Neurol 60: 369-376. PMID: 12633148
31. Selznick LA, Holtzman DM, Han BH, Gokden M, Srinivasan AN, et al. (1999) In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J Neuropathol Exp Neurol 58: 1020-1026. PMID: 10499444
32. Shimohama S, Tanino H, Fujimoto S (1999) Changes in caspase expression in Alzheimer's disease: comparison with development and aging. Biochem Biophys Res Commun 256: 381-384. PMID: 10079193
33. Reifert J, Hartung-Cranston D, Feinstein SC (2011) Amyloid beta-mediated cell death of cultured hippocampal neurons reveals extensive Tau fragmentation without increased full-length tau phosphorylation. J Biol Chem 286: 20797-20811. doi: 10.1074/jbc.M111.234674 PMID: 21482827
34. Chan HM, La Thangue NB (2001) p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 114: 2363-2373. PMID: 11559745
35. Vo N, Goodman RH (2001) CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 276: 13505-13508. PMID: 11279224
36. Huang WC, Chen CC (2005) Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol Cell Biol 25: 6592-6602. PMID: 16024795
37. Luebben WR, Sharma N, Nyborg JK (2010) Nucleosome eviction and activated transcription require p300 acetylation of histone H3 lysine 14. Proc Natl Acad Sci U S A 107: 19254-19259. doi: 10.1073/pnas.1009650107 PMID: 20974913
38. Ito A, Lai CH, Zhao X, Saito S, Hamilton MH, et al. (2001) p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J 20: 1331-1340. PMID: 11250899
39. Raz L, Zhang QG, Han D, Dong Y, De Sevilla L, et al. (2011) Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen. PLoS One 6: e27039. doi: 10.1371/journal.pone.0027039 PMID: 22046440
40. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, et al. (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12: 2831-2841. PMID: 9744860
41. Brooks CL, GuW(2011) The impact of acetylation and deacetylation on the p53 pathway. Protein Cell 2: 456-462. doi: 10.1007/s13238-011-1063-9 PMID: 21748595
42. Rodriguez MS, Desterro JM, Lain S, Lane DP, Hay RT (2000) Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol Cell Biol 20: 8458-8467. PMID: 11046142
43. Brooks CL, GuW(2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164-171. PMID: 12648672
44. van der Maarel SM, Scholten IH, Huber I, Philippe C, Suijkerbuijk RF, et al. (1996) Cloning and characterization of DXS6673E, a candidate gene for X-linked mental retardation in Xq13.1. Hum Mol Genet 5: 887-897. PMID: 8817323
45. Thomas MJ, Seto E (1999) Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 236: 197-208. PMID: 10452940
46. Gordon S, Akopyan G, Garban H, Bonavida B (2006) Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25: 1125-1142. PMID: 16314846
47. Yao YL, Yang WM, Seto E (2001) Regulation of transcription factor YY1 by acetylation and deacetylation. Mol Cell Biol 21: 5979-5991. PMID: 11486036
48. Becker KG, Jedlicka P, Templeton NS, Liotta L, Ozato K (1994) Characterization of hUCRBP (YY1, NF-E1, delta): a transcription factor that binds the regulatory regions of many viral and cellular genes. Gene 150: 259-266. PMID: 7821790
49. Korhonen P, Kyrylenko S, Suuronen T, Salminen A (2005) Changes in DNA binding pattern of transcription factor YY1 in neuronal degeneration. Neurosci Lett 377: 121-124. PMID: 15740849
50. Nowak K, Lange-Dohna C, Zeitschel U, Gunther A, Luscher B, et al. (2006) The transcription factor Yin Yang 1 is an activator of BACE1 expression. J Neurochem 96: 1696-1707. PMID: 16539685
51. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, et al. (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311-318. PMID: 17277777
52. Min SW, Cho SH, Zhou Y, Schroeder S, Haroutunian V, et al. (2010) Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67: 953-966. doi: 10.1016/j.neuron.2010.08.044 PMID: 20869593
53. Cohen TJ, Guo JL, Hurtado DE, Kwong LK, Mills IP, et al. (2011) The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat Commun 2: 252. doi: 10.1038/ncomms1255 PMID: 21427723
54. Sui G, Affar el B, Shi Y, Brignone C, Wall NR, et al. (2004) Yin Yang 1 is a negative regulator of p53. Cell 117: 859-872. PMID: 15210108
55. Gronroos E, Terentiev AA, Punga T, Ericsson J (2004) YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci U S A 101: 12165-12170. PMID: 15295102
56. de la Monte SM, Sohn YK, Wands JR (1997) Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci 152: 73-83. PMID: 9395128
57. Scheer MP, van der Maarel S, Kubart S, Schulz A, Wirth J, et al. (2000) DXS6673E encodes a predominantly nuclear protein, and its mouse ortholog DXHXS6673E is alternatively spliced in a developmen-tal- and tissue-specific manner. Genomics 63: 123-132. PMID: 10662551
58. Sankar N, Baluchamy S, Kadeppagari RK, Singhal G, Weitzman S, et al. (2008) p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc. Oncogene 27: 5717-5728. doi: 10.1038/onc.2008.181 PMID: 18542060
59. Hakimi MA, Dong Y, Lane WS, Speicher DW, Shiekhattar R (2003) A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes. J Biol Chem 278: 7234-7239. PMID: 12493763
60. Selvi BR, Cassel JC, Kundu TK, Boutillier AL (2010) Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases. Biochim Biophys Acta 1799: 840-853. doi: 10.1016/j. bbagrm.2010.08.012 PMID: 20833281
61. Vonsattel JP, Del Amaya MP, Keller CE (2008) Twenty-first century brain banking. Processing brains for research: the Columbia University methods. Acta Neuropathol 115: 509-532. PMID: 17985145
62. Wu Z, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F (2004) A Model Based Background Adjustment for Oligonucleotide Expression Arrays. Journal of the American Statistical Association 44.
63. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034. PMID: 12184808
64. Barghorn S, Nimmrich V, Striebinger A, Krantz C, Keller P, et al. (2005) Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem 95: 834-847. PMID: 16135089